Post-COVID-19 Monitoring in Routine Health Insurance Data

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

157134 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-08-01

Study Completion Date

2023-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The SARS-CoV-2 infection was in 2020 responsible for new disease related chronic conditions which have been referred to as Post-COVID. To date it is still unknown how common this condition is and which symptoms are related to it. The aim of the study is to monitor the onset of these conditions in a large observational study consisting of German health insurance data.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

COVID-19 Seroprevalence Study in ITM Staff

NCT04503447

Covid19

COMPLETED

Prevalence of NAFLD in ACS Patients

NCT05378321

NAFLD ACS - Acute Coronary Syndrome

COMPLETED NA

Reactivation of Varicella Zoster Virus and Risk of Vascular Disease

NCT02559596

Varicella Zoster Stroke Transient Ischaemic Attack +1 more

WITHDRAWN

Myocardial Infarction Rates Overview During COVID-19 Pandemic In France: MODIF Study

NCT04357314

Myocardial Infarction

COMPLETED

COVID-19 and Hereditary Metabolic Diseases

NCT04645498

Covid19 Metabolism, Inborn Errors

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

SARS-CoV-2 is a virus of the coronavirus family, which includes a large number of viruses that can cause a wide variety of diseases in humans. The SARS-CoV-2 virus causes acute symptoms associated with the infection and can cause chronic conditions known as Post-COVID. To understand the prevalence and variety of Post-COVID a large observational study of health insurance data from Germany was set up. The exposed patients were identified by a diagnosis indicating a confirmed laboratory test for COVID.

The basic question concerns the burden of the Post-COVID condition. The study investigate which symptoms are more common in humans after the exposure to the virus compared to a matched unexposed cohort. Further will this be investigated in the subgroup of children and adolescents and those who have been hospitalized due to the virus infection.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Virus Diseases Epidemiology

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Adults

145184 patients with COVID-19 over 17 years of age.

Exposed to a SARS-CoV-2 infection

Intervention Type OTHER

The study compared humans exposed to the SARS-CoV-2 infection with a matched group of those not exposed. No Intervention was applied.

Children and adolescents

11950 patients with COVID-19 under 18 years of age.

Exposed to a SARS-CoV-2 infection

Intervention Type OTHER

The study compared humans exposed to the SARS-CoV-2 infection with a matched group of those not exposed. No Intervention was applied.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Exposed to a SARS-CoV-2 infection

The study compared humans exposed to the SARS-CoV-2 infection with a matched group of those not exposed. No Intervention was applied.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* At least one outpatient or inpatient diagnosis of COVID-19 with laboratory detection of the virus (ICD-10: U07.1!)
* Continuously insured with the respective health insurance between 2019-01-01/birth and 2020-12-31/death